Page last updated: 2024-12-07

4-methylangelicin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID80934
CHEMBL ID170389
SCHEMBL ID9118095
MeSH IDM0099737

Synonyms (19)

Synonym
6457-92-7
5-19-04-00456 (beilstein handbook reference)
OPREA1_085056
4-methyl-2h-furo(2,3-h)-1-benzopyran-2-one
brn 0174731
4-methylangelicin
2h-furo(2,3-h)(1)benzopyran-2-one, 4-methyl-
OPREA1_866970
SCHEMBL9118095
CHEMBL170389
CCG-17663
8h-furo[2,3-h][1]benzopyran-8-one, 6-methyl-
HCYYGOURSFQHRV-UHFFFAOYSA-N
4-methyl-2h-furo[2,3-h]chromen-2-one #
SR-01000451428-1
sr-01000451428
4-methyl-angelicin
DTXSID50877062
2h-furo[2,3-h]-1-benzopyran-2-one, 4-methyl-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1324224Induction of melanin synthesis in mouse B16F10 cells at 50 uM after 48 hrs by spectrophotometric analysis relative to control2016Bioorganic & medicinal chemistry, 11-15, Volume: 24, Issue:22
Synthesis and biological evaluation of furocoumarin derivatives on melanin synthesis in murine B16 cells for the treatment of vitiligo.
AID68591Compound was evaluated for the inhibition of RNA synthesis in Ehrlich Ascites tumor cells by irradiation (365 nm) at 1.9 x 10 e-5M1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Methylangelicins: new potential agents for the photochemotherapy of psoriasis. Structure-activity study on the dark and photochemical interactions with DNA.
AID467954Antiproliferative activity against mouse EAC cells assessed as ratio of ID50 of compound to ID50 of 8-methoxypsoralen2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Scoring function for DNA-drug docking of anticancer and antiparasitic compounds based on spectral moments of 2D lattice graphs for molecular dynamics trajectories.
AID20131Rate constant of the photoreaction between compound and DNA.1983Journal of medicinal chemistry, Jun, Volume: 26, Issue:6
4'-Methylangelicins: new potential agents for the photochemotherapy of psoriasis.
AID68590Compound was evaluated for the inhibition of DNA synthesis in Ehrlich Ascites tumor cells by irradiation (365 nm) at 1.9 x 10 e-5M1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Methylangelicins: new potential agents for the photochemotherapy of psoriasis. Structure-activity study on the dark and photochemical interactions with DNA.
AID220351Compound was evaluated for rate constant in the calf thymus DNA1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Methylangelicins: new potential agents for the photochemotherapy of psoriasis. Structure-activity study on the dark and photochemical interactions with DNA.
AID220348Compound was evaluated for association constant in the calf thymus DNA1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Methylangelicins: new potential agents for the photochemotherapy of psoriasis. Structure-activity study on the dark and photochemical interactions with DNA.
AID21992Water solubility (solubility in mol/L)1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Methylangelicins: new potential agents for the photochemotherapy of psoriasis. Structure-activity study on the dark and photochemical interactions with DNA.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.29 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]